Universal Health Services Inc owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers... Show more
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where UHS advanced for three days, in of 345 cases, the price rose further within the following month. The odds of a continued upward trend are .
UHS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on December 31, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on UHS as a result. In of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
UHS moved below its 50-day moving average on December 30, 2025 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for UHS crossed bearishly below the 50-day moving average on December 31, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UHS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for UHS entered a downward trend on January 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.742) is normal, around the industry mean (8.170). P/E Ratio (9.513) is within average values for comparable stocks, (113.934). UHS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.844). Dividend Yield (0.004) settles around the average of (0.037) among similar stocks. P/S Ratio (0.770) is also within normal values, averaging (1.389).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. UHS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
a healthcare management company, which owns and operates acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers and radiation oncology centers
Industry HospitalNursingManagement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IYK | 69.59 | 0.26 | +0.38% |
| iShares US Consumer Staples ETF | |||
| AUSM | 25.15 | N/A | N/A |
| Allspring Ultra Short Municipal ETF | |||
| NUMI | 25.16 | -0.10 | -0.38% |
| Nuveen Municipal Income ETF | |||
| ASHS | 42.40 | -0.20 | -0.48% |
| Xtrackers Harvest CSI 500 CHN A SmCp ETF | |||
| UTEN | 43.74 | -0.22 | -0.49% |
| F/m US Treasury 10 Year Note ETF | |||
A.I.dvisor indicates that over the last year, UHS has been closely correlated with HCA. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if UHS jumps, then HCA could also see price increases.
| Ticker / NAME | Correlation To UHS | 1D Price Change % | ||
|---|---|---|---|---|
| UHS | 100% | -0.01% | ||
| HCA - UHS | 77% Closely correlated | -1.05% | ||
| THC - UHS | 69% Closely correlated | -1.77% | ||
| ENSG - UHS | 58% Loosely correlated | -1.75% | ||
| ACHC - UHS | 56% Loosely correlated | +21.92% | ||
| CON - UHS | 53% Loosely correlated | +1.67% | ||
More | ||||
| Ticker / NAME | Correlation To UHS | 1D Price Change % |
|---|---|---|
| UHS | 100% | -0.01% |
| UHS (3 stocks) | 89% Closely correlated | +0.32% |
| Hospital/Nursing Management (87 stocks) | 51% Loosely correlated | -0.78% |